Pathstone Holdings »

Intellia Therapeutics shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-03-31 $352k 13k 27.51
2023-12-31 $225k 7.4k 30.49

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Crowdstrike Hldgs Cl A (CRWD)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Pathstone Holdings

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Wellington Management Company
FMR
Geode Capital Management
Federated Investors
T. Rowe Price Associates
Alliancebernstein
Citadel Advisors
Rokos Capital Management
Casdin Capital
Contrarius Investment Management

View all funds holding Intellia Therapeutics